ERBB2 and breast cancer: The plasma level of overall VLDL resulted significantly increased in HER2-positive BC patients, in particular for their total Chol-VLDL (p = 6.9 × 10−5; q = 0.001), free-Chol (p = 0.001; q = 0.006) and PLs (p = 3.7 × 10−4; q = 0.004) contents (Table S2).